Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
Gong, L., Han, X., Silva, T., Tan, Y.C., Goyal, B., Tivitmahaisoon, P., Trejo, A., Palmer, W., Hogg, H., Jahagir, A., Alam, M., Wagner, P., Stein, K., Filonova, L., Loe, B., Makra, F., Rotstein, D., Rapatova, L., Dunn, J., Zuo, F., Dal Porto, J., Wong, B., Jin, S., Chang, A., Tran, P., Hsieh, G., Niu, L., Shao, A., Reuter, D., Hermann, J., Kuglstatter, A., Goldstein, D.(2013) Bioorg Med Chem Lett 23: 3565-3569
- PubMed: 23664880 
- DOI: 10.1016/j.bmcl.2013.04.029
- Primary Citation of Related Structures:  
4IZY - PubMed Abstract: 
A novel series of indole/indazole-aminopyrimidines was designed and synthesized with an aim to achieve optimal potency and selectivity for the c-Jun kinase family or JNKs. Structure guided design was used to optimize the series resulting in a significant potency improvement ...